Circular RNA: A novel potential biomarker for skin diseases

Pharmacol Res. 2020 Aug:158:104841. doi: 10.1016/j.phrs.2020.104841. Epub 2020 May 11.

Abstract

Circular RNA (circRNA) has been classified as noncoding RNA with a covalent closed continuous loop, the 3'and 5' ends of which are normally joined together to increase its own stability. More recently, circRNA has been shown to encode proteins and may be involved in the regulation of gene transcription. This provides more evidence for the involvement of circRNA in disease progression. Accumulating investigations have found that the expression of many circRNAs is abnormal in plenty of skin diseases such as malignant melanoma, psoriasis, and abnormal wound healing. Herein, in addition to the summary of recent studies on the nuclear export, N6-methyladenosine (m6A) modification, degradation, and other biogenesis and properties of circRNA, we highlight the importance of circRNAin skin diseases. Although their exact roles and mechanisms in most skin disease remain preliminary, circRNAs have potential applications as diagnostic biomarkers and novel therapeutic targets for skin diseases due to its structural and functional properties (stability, specificity and sensitivity), which is worthy of deeper exploration and greater research efforts.

Keywords: Biomarker; CircRNA; Melanoma; N(6)-methyladenosine (m(6)A) modification; Skin diseases; Wound healing.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers / analysis*
  • Humans
  • Psoriasis / genetics
  • RNA, Circular / analysis
  • RNA, Circular / genetics*
  • RNA, Circular / physiology
  • Skin Diseases / diagnosis*
  • Skin Diseases / drug therapy
  • Skin Diseases / genetics*

Substances

  • Biomarkers
  • RNA, Circular